US Stock MarketDetailed Quotes
ACTU Actuate Therapeutics
- 8.130
- -0.550-6.34%
Close Nov 29 13:00 ET
158.79MMarket Cap-5579P/E (TTM)
8.690High7.890Low19.06KVolume8.690Open8.680Pre Close158.33KTurnover0.68%Turnover RatioLossP/E (Static)19.53MShares10.16252wk High29.67P/B22.76MFloat Cap5.51052wk Low--Dividend TTM2.80MShs Float10.162Historical High--Div YieldTTM9.22%Amplitude5.510Historical Low8.305Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Actuate Therapeutics Stock Forum
CHICAGO and FORT WORTH, Texas, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company, focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers through the inhibition of glycogen synthase kinase-3 beta (GSK-3β), announced that it will participate in “Webinar Wednesday” hosted b...
No comment yet